Case 2:19-cv-10439-DPH-DRG ECF No. 25 filed 04/29/19 PageID.595 Page 1 of 59
UNITED STATES DISTRICT COURT EASTERN DISTRICT OF MICHIGAN
NORTH PLATE SEMICONDUCTOR, Case No. 2:19-cv-10439-DPH-DRG LLC,
Plaintiff, Judge: Hon. Denise Page Hood v. Magistrate Judge: OMNIVISION TECHNOLOGIES Hon. David R. Grand INC., TEXAS INSTRUMENTS INCORPORATED, SMART EYE INTERNATIONAL INC., SMK ELECTRONICS CORPORATION, U.S.A.
Defendants. JURY TRIAL DEMANDED
AMENDED COMPLAINT FOR PATENT INFRINGEMENT
Plaintiff North Plate Semiconductor, LLC (“NPS” or Plaintiff”) hereby
asserts a claim for patent infringement against Defendants OmniVision
Technologies, Inc. (“OmniVision”), Texas Instruments Incorporated (“Texas
Instruments”), Smart Eye International Inc. (“Smart Eye”), SMK Electronics
Corporation, U.S.A. (“SMK”)(collectively referred to as “Defendants”), and in
support thereof allege as follows:
NATURE OF CASE
1. This is an action for patent infringement arising under the patent laws
of the United States, 35 U.S.C. §1 et seq., specifically including 35 U.S.C. §271. Case 2:19-cv-10439-DPH-DRG ECF No. 25 filed 04/29/19 PageID.596 Page 2 of 59
2. As set forth below, Plaintiff holds the rights in U.S. Patent Nos.
6,211,509 (“the ‘509 patent”); 6,150,676 (“the ‘676 patent); 6,521,926 (“the ‘926
patent”); 7,928,483 (“the ‘483 patent”); 8,854,521 (“the ‘521 patent”); RE46123
(“the ‘123 patent”); 8,178,913 (“the ‘913 patent”) (cumulatively “Patents-in-Suit”).
The United States patent laws grant the holder of a patent the right to exclude
infringers from making, using, selling or importing the invention claimed in a
patent, to recover damages for the infringer’s violations of these rights, and to
recover treble damages where the infringer willfully infringed the patent. Under 35
U.S.C. § 282(a), the Patents-in-Suit are entitled to a presumption of validity.
Plaintiff is suing Defendants for infringing its patents, and doing so willfully.
Plaintiff seeks to recover damages from Defendants, including treble damages for
willful infringement.
THE PARTIES
3. North Plate Semiconductor, LLC is a company, organized and
existing under the laws of the Delaware, with a principal place of business at
39555 Orchard Hill Place, Suite 600, Novi, Michigan, 48375.
4. Upon information and belief, Defendant OmniVision Technologies,
Inc., is a corporation organized and existing under the laws of the State of
Delaware with a principal place of business at 4275 Burton Drive, Santa Clara,
2 Case 2:19-cv-10439-DPH-DRG ECF No. 25 filed 04/29/19 PageID.597 Page 3 of 59
California 95054, and a regular and established place of business at 27280
Haggerty Road, Suite C15, Farmington Hills, Michigan, 48331.
5. Upon information and belief, Defendant Texas Instruments
Incorporated is a corporation organized and existing under the laws of the State of
Delaware with a principal place of business at 12500 TI Boulevard, Dallas, Texas
75243, and a regular and established place of business at 29777 Telegraph Road,
Suite 2500, Southfield, Michigan 48034.
6. Upon information and belief, Defendant Smart Eye International Inc.
is a corporation organized and existing under the laws of the State of Delaware
with its principal place of business at 455 E. Eisenhower Parkway, Suite 300, Ann
Arbor, Michigan 48108.
7. Upon information and belief, Defendant SMK Electronics
Corporation, U.S.A., is a corporation organized and existing under the laws of the
State of California with a principal place of at 1055 Tierra del Rey, Chula Vista,
California 91910, and a regular and established place of business at 39209 Six
Mile Road, Suite #206, Livonia, Michigan 48152.
JURISDICTION
8. This is an action for patent infringement arising under the patent laws
of the United States of America, more specifically under 35 U.S.C. § 1, et seq.,
3 Case 2:19-cv-10439-DPH-DRG ECF No. 25 filed 04/29/19 PageID.598 Page 4 of 59
including 35 U.S.C. §271. This Court has subject matter jurisdiction pursuant to 28
U.S.C. §§ 1331 and 1338(a).
9. This Court has personal jurisdiction over Defendants because each
Defendant, among other things, conducts business in, and avail themselves to the
laws of, the State of Michigan. Upon information and belief, as set forth above in
paragraphs 4 through 7, each Defendant has a regular and established place of
business within this judicial district. Each Defendant has purposefully and
regularly availed themselves of the privileges of conducting business in the State
of Michigan and in the Eastern District of Michigan and expected or reasonably
should have expected its acts to have consequence in the State of Michigan and
within this judicial District. Plaintiff’s cause of action arises directly from each
Defendants’ business contacts and other activities in the State of Michigan and in
this District. Each Defendant have committed acts of patent infringement in this
District, and have harmed and continue to harm Plaintiff in this District, by, among
other things, using, selling, offering for sale, and/or importing the Accused
OmniVision Products (as defined below) in this District.
VENUE
10. Venue properly lies within this judicial district and division, pursuant
to 28 U.S.C. §§ 1391 and 1400(b) because, as set forth above in paragraphs 4
4 Case 2:19-cv-10439-DPH-DRG ECF No. 25 filed 04/29/19 PageID.599 Page 5 of 59
through 7, each Defendant has regular and established place of business within the
district and have committed acts of infringement within the district.
11. Upon information and belief, each Defendant separately maintains
and operates places of business within this district. Defendant OmniVision’s acts
of infringement within the district include, but are not limited to, selling and
offering for sale the Accused OmniVision Products (as defined herein) within the
district to its distributor, Arrow Electronics located in Plymouth, MI. Each
Defendant’s acts of infringement within this district include, but are not limited to,
selling and offering for sale products that incorporate the Accused OmniVision
Products within this judicial district. Likewise, each Defendant resides in this
District for the purposes of venue, insofar as they are subject to the personal
jurisdiction in this District, solicit business in this District, conduct other business
in this District, and have committed acts of infringement in this District.
THE PATENTS-IN-SUIT
U.S. Patent No. 6,211,509
12. The ‘509 patent, entitled “Semiconductor Device And Method For
Manufacturing The Same,” was duly and lawfully issued by the United States
Patent and Trademark Office on May 8, 2012. The ‘509 patent issued from U.S.
Patent Application No. 12/714,586 filed on March 1, 2010 by inventors Hideki
Okumura, Takayoshi Nogami, Hiroto Misawa. A true and correct copy of the ‘509
5 Case 2:19-cv-10439-DPH-DRG ECF No. 25 filed 04/29/19 PageID.600 Page 6 of 59
patent is attached hereto as Ex. A.
13. The ‘509 patent is valid and enforceable.
14. Plaintiff is the assignee and the owner of all right, title and interest in
and to the ‘509 patent, and has the right to sue and recover damages for
infringement thereof.
U.S. Patent No. 6,150,676
15. The ‘676 patent, entitled “MOS Type Image Sensor,” was duly and
lawfully issued by the United States Patent and Trademark Office on November
21, 2000. The ‘676 patent issued from U.S. Patent Application No. 09/266,007
filed on Mach 11, 1999 by inventor Michio Sasaki. A true and correct copy of the
‘676 Patent is attached hereto as Ex. B.
16. The ‘676 Patent is valid and enforceable.
17. Plaintiff is the assignee and the owner of all right, title and interest in
and to the ‘676 patent, and has the right to sue and recover damages for
infringement thereof.
U.S. Patent No. 6,521,926
18. The ‘926 patent, entitled “MOS Type Image Sensor,” was duly and
lawfully issued by the United States Patent and Trademark Office on February 18,
2003. The ‘926 patent issued from U.S. Patent Application No. 09/695,989 filed on
6 Case 2:19-cv-10439-DPH-DRG ECF No. 25 filed 04/29/19 PageID.601 Page 7 of 59
October 26, 2000 by inventor Michio Sasaki. A true and correct copy of the ‘926
Patent is attached hereto as Ex. C.
19. The ‘926 Patent is valid and enforceable.
20. Plaintiff is the assignee and the owner of all right, title and interest in
and to the ‘926 patent, and has the right to sue and recover damages for
infringement thereof.
U.S. Patent No. 7,928,483
21. The ‘483 patent, entitled “Semiconductor Device and Method for
Manufacturing the Same,” was duly and lawfully issued by the United States
Patent and Trademark Office on April 19, 2011. The ‘483 patent issued from U.S.
Patent Application No. 12/388,667 filed on February 19, 2009 by inventors Atushi
Murakoshi and Katsunori Yahashi. A true and correct copy of the ‘483 Patent is
attached hereto as Ex. D.
22. The ‘483 Patent is valid and enforceable.
23. Plaintiff is the assignee and the owner of all right, title and interest in
and to the ‘483 patent, and has the right to sue and recover damages for
infringement thereof.
U.S. Patent No. 8,854,521
24. The ‘521 patent, entitled “Solid-State Image Sensing Device and
Control Method of Solid-State Image Sensing Device,” was duly and lawfully
7 Case 2:19-cv-10439-DPH-DRG ECF No. 25 filed 04/29/19 PageID.602 Page 8 of 59
issued by the United States Patent and Trademark Office on October 7, 2014. The
‘521 patent issued from U.S. Patent Application No. 13/603,728 filed on
September 5, 2012 by inventors Tomonori Yamashita and Tomohiro Matsuura. A
true and correct copy of the ‘521 Patent is attached hereto as Ex. E.
25. The ‘521 Patent is valid and enforceable.
26. Plaintiff is the assignee and the owner of all right, title and interest in
and to the ‘521 patent, and has the right to sue and recover damages for
infringement thereof.
U.S. Patent No. RE46123
27. The ‘123 patent, entitled “Solid-State Image Sensor and Method of
Manufacturing the Same,” was duly and lawfully issued by the United States
Patent and Trademark Office on August 23, 2016. The ‘123 patent issued from
U.S. Patent Application No. 14/595,464 filed on January 13, 2015 by inventors
Mariko Saito, Ikuko Inoue, and Takeshi Yoshida. A true and correct copy of the
‘123 Patent is attached hereto as Ex. F.
28. The ‘123 Patent is valid and enforceable.
29. Plaintiff is the assignee and the owner of all right, title and interest in
and to the ‘123 patent, and has the right to sue and recover damages for
infringement thereof.
U.S. Patent No. 8,178,913
8 Case 2:19-cv-10439-DPH-DRG ECF No. 25 filed 04/29/19 PageID.603 Page 9 of 59
30. The ‘913 patent, entitled “Semiconductor Device And Method For
Manufacturing Same,” was duly and lawfully issued by the United States Patent
and Trademark Office on May 15, 2012. The ‘913 patent issued from U.S. Patent
Application No. 12/926,771 filed on December 8, 2010 by inventors Atushi
Murakoshi and Katsunori Yahashi. A true and correct copy of the ‘913 Patent is
attached hereto as Ex. G.
31. The ‘913 Patent is valid and enforceable.
32. Plaintiff is the assignee and the owner of all right, title and interest in
and to the ‘913 patent, and has the right to sue and recover damages for
infringement thereof.
GENERAL ALLEGATIONS
33. The Accused OmniVision Products include at least Defendant
OmniVision’s CMOS image sensor products, including but not limited to the
OV8850 and OV13850 devices (collectively defined as the “Accused OmniVision
Products”). As stated on OmniVision’s website, these image sensors are used in
the automotive, medical imaging, mobile device, surveillance,
AR/VR/Drones/Robotics, and computing industries. These products are sold
and/or offered for sale throughout the United States, including Michigan.
34. OmniVision designs, develops, engineers and manufactures the
Accused OmniVision Products, and directly, and through its affiliates, makes, uses,
9 Case 2:19-cv-10439-DPH-DRG ECF No. 25 filed 04/29/19 PageID.604 Page 10 of 59
imports, sells and offers to sell the same throughout the United States, including in
this district in Michigan. OmniVision also supports and encourages others to
import, use, offer for sale and sell throughout the United States, including in this
district in Michigan, products incorporating the Accused OmniVision Products.
35. The Accused OmniVision Products have and continue to be used, sold
and/or offered for sale within the United States, including in this district, thus
constituting direct infringement under 35 U.S.C. § 271(a) by entities other than
Defendant OmniVision (hereinafter, the “Direct Infringers”). Motorola has been
and continues to be a customer of OmniVision.1 Motorola sells and has sold the
Moto X within the United States, which incorporates OmniVision’s OV10820
image sensor. (Ex. P). Motorola sells and has sold the Moto Z Droid and the
Moto Z Force Droid within the United States, which each incorporate the
OmniVision OV5693 image sensor. (Ex. Q). Motorola sells and has sold the
Moto Z within the United States, which incorporates OmniVision’s OV16860
image sensor. (Ex. R). Motorola sells and has sold the Moto G4 Plus within the
United States, which incorporates OmniVision’s OV16860 and OV5693 image
sensors. (Ex. S). Lenovo has been and continues to be a customer of OmniVision.
Lenovo sells and has sold the Lenovo K3 Note and the Lenovo K8 Plus within the
1 Godo Kaisha IP Bridge 1 v. OmniVision Technologies, Inc., Civil Action No. 16- 290 (D. Del.) (Dkt. 168 ¶4, Feb. 5, 2019, Decl. of Michelle Milunovic).
10 Case 2:19-cv-10439-DPH-DRG ECF No. 25 filed 04/29/19 PageID.605 Page 11 of 59
United States, which each incorporate OmniVision’s OV13850 image sensor. (Ex.
T). Lenovo sells and has sold the Lenovo K8 Note, which incorporates
OmniVision’s OV13855 image sensor. (Ex. U). Lenovo sells the Lenovo Z5
within the United States, which incorporates OmniVision’s OV16855 image
sensor. (Ex. V). Lenovo sells and has sold the MotoG Plus within the United
States, which incorporates OmniVision’s image sensors. (Ex. W). Microsoft sells
and has sold Surface Pro 2017 within the United States, which incorporates
OmniVision’s OV5693 and OV7251 image sensors. (Ex. X). Microsoft sells and
has sold Surface Pro 4 within the United States, which incorporates OmniVision’s
OV5693 and OV8865 image sensors. (Ex. Y). Apple sells and has sold versions
of iPad within the United States, which includes OmniVision’s OV5650, and iPod
Nano and iPad 2 within the United States, which incorporates OmniVision’s
OV297. (Ex. Z). Apple sells and has sold iPhone 5S within the United States,
which incorporates OmniVision’s OV2724 image sensor. (Ex. AA). Apple sells
and has sold iPad 3 and iPhone 4S within the United States, which incorporates
OmniVision’s OV5650 image sensor. (Ex. BB). Samsung sells and has sold the
Galaxy S3 and Galaxy S2 within the United States, which incorporates
OmniVision’s OV5650 image sensor. (Id.). HTC sells and has sold the HTC One
X within the United States, which incorporates OmniVision’s OV5650 image
sensor. (Id.). Smart Eye sells and has sold a sensing algorithm product to
11 Case 2:19-cv-10439-DPH-DRG ECF No. 25 filed 04/29/19 PageID.606 Page 12 of 59
automotive OEMs within the United States, which incorporates OmniVision’s
OV2311 image sensor. (Ex. CC). SMK sells and has sold a camera module for
Tesla automobiles within the United States, which incorporates OmniVision’s
OV10635 image sensor. (Ex. CC). Texas Instruments sells and has sold
Automotive ADAS system-on-chip (SoC) processors TDA2x, TDA2Eco and
TDA3x within the United States, which incorporates OmniVision’s 10635 image
sensor. (Ex. DD at 9). For the reasons alleged elsewhere herein, including within
the attached preliminary infringement claim charts (Exs. I through O) each of the
foregoing constitute specific examples of direct infringement of the Patents-in-Suit
within the United States by the Direct Infringers.
36. Actual sales, offers for sales and uses by third parties, including,
without limitation, the Direct Infringers, have and continue to occur within the
United States. By way of example, Arrow Electronics has and continues to use,
sell and offer for sale the Accused OmniVision Products at specific prices within
the United States. (Ex. BBB). Arrow’s offer for sale of the Accused OmniVision
Products indicates that, when sold, the Accused OmniVision Products “Ships from:
United States of America.” (Id.). Similarly, Digi-Key has and continues to use,
sell and offer for sale the Accused OmniVision Products at specific prices within
the United States. (Ex. CCC). OmniVision’s website expressly identifies Arrow
12 Case 2:19-cv-10439-DPH-DRG ECF No. 25 filed 04/29/19 PageID.607 Page 13 of 59
and Digi-Key as distribution channels for the Accused OmniVision Products
within regions including the United States. (Ex. AAA).
37. Thus, Defendant OmniVision has and continues to intentionally
induce others, including the Direct Infringers, to directly infringe in violation of 35
U.S.C. §271(b), and those actions are undertaken with the specific intent that they
will, in fact, induce direct infringement and with full knowledge that Defendant
OmniVision’s products infringe one or more claims of each of the Patents-in-Suit
both literally and/or under the doctrine of equivalents. By way of example only,
Defendant OmniVision sells and delivers the infringing Accused OmniVision
Products to U.S. distributors including Arrow Electronics located in Plymouth, MI,
Mouser Electronics located in Mansfield, TX, Digi-Key Electronics located in
Thief River Falls, MN and others, and thereafter induces these distributors to sell
and offer for sale the infringing products to customers in the United States thereby
directly infringing each of the Patents-in-Suit. Arrow Electronics, Mouser
Electronics and Digi-Key maintain websites (arrow.com, mouser.com and
www.digikey.com) available to U.S.-based customers that, as a result of Defendant
OmniVision’s inducement, stock, sell, and offer for sale the Accused OmniVision
Products. Defendant OmniVision further induces third parties to incorporate the
Accused OmniVision Products as components into additional products for various
applications to be used in the United States, by, for example, providing datasheets,
13 Case 2:19-cv-10439-DPH-DRG ECF No. 25 filed 04/29/19 PageID.608 Page 14 of 59
application notes, product briefs, and other collateral on their Internet website
(http://www.ovt.com) available to U.S. customers.
38. Defendant OmniVision has and continues to specifically intend the
Direct Infringers to infringe the Patents-in-Suit. Defendant OmniVision has and
continues to engage in affirmative acts evidencing this specific intent. For
instance, Defendant OmniVision has and continues to specifically intend the Direct
Infringers to infringe the Patents-in-Suit by affirmatively advertising, promoting
and touting benefits, features and functions of the Accused OmniVision Products
that mirror the benefits, functions and features of the inventions claimed in the
Patents-in-Suit.
39. The ‘509 patent is directed to a solid-state image sensor. In the
particular, the ‘509 patent claims, according to claim 1, inter alia, a solid-state
image sensor comprising a plurality of pixels, a scanning circuit and “element
isolation regions configured to isolate said pixel units from each other.” In a
preferred embodiment, the element isolation regions are formed of a field oxide
film, below which are p-type diffusion layers that have impurity concentrations
higher than the substrate. (‘509 patent col. 6:29-50). As a result, “charges
generated in a deep portion of the semiconductor substrate [] by long-wavelength
light entering a deep layer of the substrate can be confined to one pixel unit to
prevent leakage of the charges into the adjacent pixel units.” (Id. col. 6:59-63).
14 Case 2:19-cv-10439-DPH-DRG ECF No. 25 filed 04/29/19 PageID.609 Page 15 of 59
This reduces color mixture and blooming. (Id. col. 6:63-66). Defendant
OmniVision touts that the Accused OmniVision Products with Nyxel® technology
achieves “deep trench isolation” that “creates a barrier between the pixels to
eliminate crosstalk and improve modular transfer function.”(Ex. PP). Defendant
OmniVision touts that the Accused OmniVision Products with Purecel®
technology offers “blooming suppression.”2 Defendant OmniVision touts that
Accused OmniVision Products with Purecel®Plus technology “reduces crosstalk
by creating isolation walls between pixels inside silicon for better chief ray angle
(CRA) tolerance. PureCel®Plus gen-2 introduces improve DTI [deep trench
isolation] for even better pixel isolation and low-light performance.” (Ex. QQ).
Defendant OmniVision also claims that DTI “prevents light from crossing over to
neighboring pixels, which significantly reduces crosstalk.” 3 Defendant
OmniVision touts that Accused OmniVision Products with OmniBSI Technology
have “reduced pixel crosstalk, high quantum efficiency, improved low-light
sensitivity.” (Ex. RR).
40. The ‘676 patent is directed to MOS type image sensor. In the
particular, the ‘676 patent claims, according to claim 17, inter alia, a MOS type
image sensor comprising a photodiode, a read transistor and an amplification
2 https://www.ovt.com/purecel-pixel-tech/purecel at 0:48 (last accessed 4/11/19)
3 https://www.ovt.com/purecel-pixel-tech/purecel-plus at 1:17 (last accessed 4/11/19)
15 Case 2:19-cv-10439-DPH-DRG ECF No. 25 filed 04/29/19 PageID.610 Page 16 of 59
transistor with unique structures as recited in the claims. In a preferred
embodiment, the ‘676 patent discloses that the technical advantages of the
disclosed MOS type image sensor within the ‘676 patent include preventing
“white” pixels, otherwise known as black or defect pixels. Defendant OmniVision
touts that the “features” of example Accused OmniVision Products include support
for “dynamic DPC cancellation,”(Ex. SS) where DPC stands for “defect pixel
correction.”(Ex. TT). Numerous Accused OmniVision Products are touted for
dynamic DPC cancellation. The ‘676 patent also discloses that another technical
advantage of the disclosed MOS type image sensor includes improving sensitivity
to light and securing spectral sensitivity in a long wavelength spectrum. (‘676
patent col. 10:1-2). Defendant OmniVision touts that the Accused OmniVision
Products with Purecel® technology offers “higher sensitivity.” 4 Defendant
OmniVision touts that Accused OmniVision Products with OmniBSI (Ex. RR)
Technology have “reduced pixel crosstalk, high quantum efficiency, improved
low-light sensitivity.” The ‘676 patent also discloses that another technical
advantage of the disclosed MOS type image sensor includes lowering the signal
read voltage. The ‘676 patent also discloses that another technical advantage of
the disclosed MOS type image sensor includes Defendant OmniVision also touts
4 https://www.ovt.com/purecel-pixel-tech/purecel at 0:46 (last accessed 4/11/19)
16 Case 2:19-cv-10439-DPH-DRG ECF No. 25 filed 04/29/19 PageID.611 Page 17 of 59
that the Accused OmniVision Products with Purecel® technology offers “lower
power consumption,”5 and “best-in-class power efficiency.” (Ex. UU).
41. The ‘483 patent is directed to semiconductor device. In the particular,
the ‘483 patent claims, according to claim 1, inter alia, a semiconductor device
comprising a buried dialetric film and an element isolation film with a unique
structure that reduces the thickness of the overall device. (‘483 patent col. 6:49-
7:29). Defendant OmniVision touts that Accused OmniVision Products with
OmniBSI (Ex. RR). Technology have “enables thinner camera modules.”
Defendant OmniVision touts other Accused OmniVision Products “designed for
slim notebooks, tablets, handsets, and other devices that require a thin bezel.”(Ex.
VV). Specifically, Defendant OmniVision touts, for example, “[t]o fit ultra-thin
bezel devices, the OV9734 comes in a compact package that can meet 2.5 mm z-
height and is 47 percent smaller in y-dimension compared to the previous
generation 720p sensor.” (Ex. VV). Defendant OmniVision touts other Accused
OmniVision Products as enabling “ultra-thin camera modules.” (Ex. WW).
42. The ‘913 patent is directed to a semiconductor device. In the
particular, the ‘913 patent claims, according to claim 1, inter alia, a semiconductor
device comprising a buried dialetric film and an element isolation film, where “a
5 https://www.ovt.com/purecel-pixel-tech/purecel at 0:30; 0:47; 1:39 (last accessed 4/11/19)
17 Case 2:19-cv-10439-DPH-DRG ECF No. 25 filed 04/29/19 PageID.612 Page 18 of 59
lower surface of the buried dialectric film being at a level higher than a lower
surface of the first-conductive-type region.” (‘913 patent col. 18:36-38). In a
preferred embodiment, the ‘913 patent discloses that pixel sensitivity is increased
when the lower surface of the buried dialectric is not lower than the first-
conductivity photodiode region. (Id. col. 14:26-31). Otherwise, the dialectric
“encroaches into the portion of the photodiode 43 having the maximum impurity
concentration and significantly decreases the amount of impurities available for
photoelectric conversion.” (Id.). Defendant OmniVision touts that Accused
OmniVision Products with Purecel®6 and Purecel®Plus technolog7 include “higher
sensitivity.” Defendant OmniVision touts that Accused OmniVision Products with
OmniBSI (Ex. RR) Technology have “reduced pixel crosstalk, high quantum
efficiency, improved low-light sensitivity.”
43. The ‘123 patent is directed to a solid-state image sensor. In particular,
the claims of the ‘123 patent are direct to a solid-state image sensor comprising,
inter alia, specific structure for interconnects and dummy layers formed in certain
surfaces of the device. (‘123 patent col. 11:15-58). This structure, in a preferred
embodiment, reduces adhesion defects between layers of the claimed device. (Id.
col. 6:30-40; col. 10:42-63). Defendant OmniVision touts that the Accused
6 https://www.ovt.com/purecel-pixel-tech/purecel at 0:46 (last accessed 4/11/19)
7 https://www.ovt.com/purecel-pixel-tech/purecel-plus at 0:44 (last accessed 4/11/19)
18 Case 2:19-cv-10439-DPH-DRG ECF No. 25 filed 04/29/19 PageID.613 Page 19 of 59
OmniVision Products, have features that “reduc[e] artifacts and increas[e] system
reliability,” (Ex. DDD) and meet all “market requirements in terms of performance,
quality and reliability.” (Ex. EEE)
44. The ‘926 patent is directed to a solid-state image sensor. In particular,
the ‘926 patent claims, according to claim 8, inter alia, a MOS type image sensor
having an image area containing an array of pixels, comprising a photodiode for
generating charges, a read transistor having a first gate electrode and an
amplification transistor having a second gate electrode, with a gate length defined
by the second gate electrode shorter than the gate length defined by the first gate
electrode of the read transistor. In one embodiment, “to suppress a punch-through
current flowing between the source and drain regions of the read MOSFET Q2, the
first embodiment makes the gate length l1 of the control electrode 23 of the read
MOSFET Q2 larger than the gate length l0 of any one of the other MOSFETs, as
shown in FIGS. 4 and 5.” (‘926 patent col. 10:21-26). As a result, “[t]his secures
good pixel characteristics.” (Id. col. 10:30). The ‘926 patent discloses that such
embodiment “provides the following technical advantages when employing fine
MOSFETs for the MOS type image sensor: (1) preventing ‘white pixels’ due to
junction leakage currents; (2) improving sensitivity to light and securing spectral
sensitivity in a long wavelength spectrum; and (3) lowering a signal read voltage.”
(Id. col. 10:7-14). Defendant OmniVision touts that the “features” of the Accused
19 Case 2:19-cv-10439-DPH-DRG ECF No. 25 filed 04/29/19 PageID.614 Page 20 of 59
OmniVision Products include “dramatically improved pixel performance” and
“best-in-class low- and high-light performance.” (Ex. UU). The ‘926 patent also
discloses that another technical advantage of the disclosed MOS type image sensor
includes improving sensitivity to light and securing spectral sensitivity in a long
wavelength spectrum. (‘926 patent col. 3:36-39). Defendant OmniVision touts
that the Accused OmniVision Products with Purecel® technology offer “higher
sensitivity” and “better low-light sensitivity.”8 The ‘926 patent also discloses that
another technical advantage of the disclosed MOS type image sensor includes
lowering the signal read voltage. (Id. col. 10:12-14). Defendant OmniVision also
touts that the Accused OmniVision Products with Purecel® technology offer
“lower power consumption”9 and “best-in-class power efficiency.” (Ex. UU).
45. The ‘521 patent is directed to a solid-state image sensor. In particular,
the ‘521 patent claims, according to claim 1, inter alia, a solid-state image sensing
device comprising a pixel including a photoelectric conversion element (e.g.,
photodiode), a signal detection unit, field effect transistors and a control signal
selection circuit to select a control signal applied to the control signal line. The
control signal selection circuit sets a potential of the control signal line applied to
the drain of the reset transistor at three levels that are of different magnitudes from
8 https://www.ovt.com/purecel-pixel-tech/purecel at 0:46 (last accessed 4/11/19)
9 https://www.ovt.com/purecel-pixel-tech/purecel at 0:30; 0:47; 1:39 (last accessed 4/11/19)
20 Case 2:19-cv-10439-DPH-DRG ECF No. 25 filed 04/29/19 PageID.615 Page 21 of 59
each other. (‘521 patent, Abstract; col. 9:1-7). The ‘521 patent discloses that the
application period of the high potential in the driving sequence of the image sensor
is reduced “since the application period of the high potential is partially replaced
by that of the medium potential lower than the high potential.” (Id. col. 9:12-16).
This results in suppression of degradations of elements. (Id. col. 9:16-18) Also,
since the medium potential (higher than the low potential) is applied to the drain of
the reset transistor of each pixel, “a potential difference between neighboring
pixels can be reduced compared to a case in which the low potential is applied to
the reset transistor 62 of the pixel 6.” (Id. col. 9:19-26) Therefore, “a charge
leakage between neighboring pixels . . . can be suppressed,” resulting in improved
reliability and image quality of the sensor. (Id. col. 9:27-29). Defendant
OmniVision touts that the Accused OmniVision Products with OmniBSI-2
technology offer “advanced image quality” and “an increase in low-light
performance, improvements in quantum efficiency, and full-well capacity – and
increase die per wafer.” (Ex. XX). Defendant Omnivision also touts reliability of
its sensors which “aim[s] to drive down the cost, power, and space requirements of
implementing vision-based driver monitoring systems without sacrificing image
quality or product reliability.” (Ex. YY). Defendant OmniVision touts that
Accused OmniVision Products with OmniBSI (Ex. RR). Technology have
“reduced pixel crosstalk, high quantum efficiency, improved low-light sensitivity.”
21 Case 2:19-cv-10439-DPH-DRG ECF No. 25 filed 04/29/19 PageID.616 Page 22 of 59
As discussed in connection with the ‘509 patent, Defendant OmniVision also
claims that DTI “prevents light from crossing over to neighboring pixels, which
significantly reduces crosstalk.”10
46. Defendant OmniVision has and continues to specifically intend the
Direct Infringers to infringe the Patents-in-Suit, and Defendant OmniVision has
and continues to engage in affirmative acts evidencing this specific intent. For
example, Defendant OmniVision affirmatively designs the Accused OmniVision
Products to infringe the Patents-in-Suit by pursuing design wins. Defendant
OmiVision has stated, “Our success has been, and will continue to be, dependent
upon manufacturers and their customers designing our image-sensor products into
their products. To achieve design wins, which are decisions by manufacturers and
their customers to design our products into their systems, we must define and
deliver cost effective and innovative image-sensor solutions on a timely basis that
satisfy the manufacturers' and their customers' requirements and specifications.”
(OmniVision 10K for fiscal year ended April 2015 at 28). Thus, Defendant
OmniVision affirmatively designs its image sensors to comply with their
manufacturers and their customers’ requirements and specifications, and therefore
affirmatively acts to specifically intend its customers, end customers and/or design-
10 https://www.ovt.com/purecel-pixel-tech/purecel-plus at 1:17 (last accessed 4/11/19)
22 Case 2:19-cv-10439-DPH-DRG ECF No. 25 filed 04/29/19 PageID.617 Page 23 of 59
win targets to intentionally infringe the Patents-in-Suit by knowingly and
intentionally incorporating the Accused OmniVision Products into their products
sold and/or offered for sale within the United States.
47. Defendant OmniVision has and continues to specifically intend the
Direct Infringers to infringe the Patents-in-Suit, and Defendant OmniVision has
and continues to engage in affirmative acts evidencing this specific intent. For
example, Defendant OmniVision provides customer support to its customers
and/or other companies incorporating the Accused OmniVision Products. As an
example, Defendant OmniVision employs, or has employed, a customer support
personnel named Don Boe, who resides in Chicago and appears to provide
customer support for Motorola. (Ex. EE). Motorola is one of OmniVision’s
customers. (Ex. OO ¶4). Motorola has a location in Chicago. Mr. Boe previously
worked for Motorola. (Ex. EE). Mr. Boe’s “identity, location, and assignment to
Motorola . . . disclose how OmniVision locates customer support representatives in
relation to its customers as part of its marketing and support strategies.” (See Godo
Kaisha IP Bridge 1 v. OmniVision Technologies, Inc., Civil Action No. 16-290 (D.
Del.) (Dkt 166 at 2). According, Defendant OmniVision affirmatively staffs
customer support personnel with former employees of customers or end customers.
Defendant OmniVision thus offers customer support for its customers and/or end
customers incorporating the Accused OmniVision Products, and therefore
23 Case 2:19-cv-10439-DPH-DRG ECF No. 25 filed 04/29/19 PageID.618 Page 24 of 59
affirmatively acts to specifically intend its customers, end customers or design-win
targets to intentionally infringe the Patents-in-Suit by knowingly and intentionally
inducing them to incorporate the Accused OmniVision Products into their products
that are sold and/or offered for sale within the United States.
48. Defendant OmniVision is knowledgeable of the end customers for the
Accused OmniVision Products in the United States, and Defendant OmniVision is
knowledgeable of the end customer products sold and/or offered for sale within the
United States that incorporate the Accused OmniVision Products. For example,
Defendant OmniVision has admitted being knowledgeable that its image sensors
were previously incorporated into certain Apple iPhone products. (See In re
OmniVision Technologies, Inc. Securities Litigation, Case No. 5:11-5235-RMW,
Dkt. 147, ¶50). Defendant Omnivision has touted that it is “No. 2” in automotive
in terms of CIS (contact image sensor) shipments. OmniVision has the third-
largest market share of the automotive image sensor market. Defendant is
therefore knowledgeable of other end customers within the United States for
products sold and/or offered for sale that incorporate the Accused OmniVision
Products.
49. In addition, Defendant OmniVision actively solicits technical support
inquiries from “OEMs” and “End Users” in regions including “North American -
Western,” “North American - Central,” and “USA/Canada – Eastern,” as well as
24 Case 2:19-cv-10439-DPH-DRG ECF No. 25 filed 04/29/19 PageID.619 Page 25 of 59
specifically from companies within the “United States” (under Country, which is a
required input). (Ex. ZZ). Defendant OmniVision has numerous distribution
channels within North America, including distributors located in Colorado (Arrow)
and Minnesota (Digi-key) to support its customers “around the globe.” (Ex. AAA).
Defendant OmniVision also affirmatively pursues “design wins” from end
customers located within the United States so that end customers will incorporate
the Accused OmniVision Products into their products. (OmniVision 10K for fiscal
year ending April 2015 at 28). These “design wins” provide Defendant
OmniVision with knowledge of end customers within the United States for
products sold and/or offered for sale that incorporate the Accused OmniVision
Products.
50. In addition, Defendant OmniVision employs personnel in the United
States to engage and maintain “key relationships” with customers and end
customers whose products are sold and offered for sale in the United States and
incorporate the Accused OmniVision Products. These customers and end
customers include Valeo, Kyocera, Panasonic, Sharp, Bosch, Continental,
Motorola, Blackberry, HP and Dell. (Ex. FF). Defendant OmniVision is also
knowledgeable the Accused OmniVision Products are incorporated into end user
products sold by Apple, Google, Amazon, Intel, Microsoft (Ex. OO); Apple,
Huawei, Sony, Xiaomi (Ex. GG); Apple, LG, Xiaomi, Dahua (Ex. HH).
25 Case 2:19-cv-10439-DPH-DRG ECF No. 25 filed 04/29/19 PageID.620 Page 26 of 59
Defendant OmniVision employs account managers that are specifically responsible
for “sales program management and business development” for “North American
regions” (Ex. II). Defendant OmniVision employs personnel to cooperate with
“[nine] worldwide company sales regions to identify customer requirements,
competitor strategies and market trends, defining next-generation product to meet
market demand.” (Ex. JJ).
51. Defendant OmniVision specifically tracks sales of end user products
sold and/or offered for sale within the United States of products incorporating the
Accused OmniVision Products into the Unite States. Defendant OmniVision
employs personnel to specifically “[m]anage the US Distribution Sales into US . . .
market[] for various applications such as Medical, Security/IOT, Automotive . . . .”
(Ex. KK). Defendant OmniVision employs personnel to “[g]enerate OmniVision
awareness within distribution to increase sales and product knowledge; by
providing sales and marketing tools and updated product information on a regular
basis to distribution sales force” (Id.). This includes “[t]rack[ing] US distribution
point of sale sell [sic] through on a monthly basis to monitor growth” (Id.).
52. Defendant OmniVision affirmatively engages with end customers in
the United States and in this district. In the automotive segment, as an example,
Defendant OmniVision employs personnel whose job responsibilities include
affirmatively engaging with end customers in the United States so that those end
26 Case 2:19-cv-10439-DPH-DRG ECF No. 25 filed 04/29/19 PageID.621 Page 27 of 59
customers will incorporate the Accused OmniVision Products into their products
for sale and/or offer for sale within the United States. Those employees have job
responsibilities including: “enabling automotive camera sensor and ISP solutions
for the North American region” (Ex. LL); business development, marketing, sales
and other tasks “in the field of automotive and autonomous mobility” (Ex. MM);
“identify[ing] growth opportunities in the Automotive camera space, then develop
and grow those opportunities” (Ex. NN); ensuring that OmniVision capitalizes on
“[a]dvanced driver assistance systems involving digital camera technology,” which
is “one of the largest growth opportunities in the automotive sector” (Id.);
“working with key Automotive customers in the Detroit Metro Area,” in a “highly
visible position” that includes management of “multiple accounts within the
Detroit region” (Job posting, OmniVision Technologies, Inc., Senior-Sales
Manager-Detroit, Farmington Hills, MI); “driv[ing] growth for automotive
segment in North America” (Ex. Job posting, OmniVision Technologies, Inc., Sr.
Automotive Marketing Manager, Farmington Hills, MI). In the automotive
segment alone, Defendant OmniVision therefore tracks the end customers of the
Accused OmniVision Products.
53. Defendant OmniVision’s 10K for fiscal year ended April 2015
reported that annual sales in the United States accounted for only 0.9% of total
revenues (or roughly $11.8 million dollars). (pp. 67, 124). Yet, Defendant
27 Case 2:19-cv-10439-DPH-DRG ECF No. 25 filed 04/29/19 PageID.622 Page 28 of 59
OmniVision stated, “[t]he revenues we report by geography are based on the
country or region in which our customers issue their purchase orders to us . . .
Because of the preponderance of Asia-Pacific manufacturers and the fact that
virtually all products incorporating our image-sensor products are sold globally, we
believe that the geographic distribution of our sales does not accurately reflect the
geographic distribution of sales into end-user markets of products which
incorporate our image sensors.” (p. 67). Defendant OmniVision employs
numerous personnel to manage, analyze and sell to end customers in the United
States and in this district. Thus, Defendant OmniVision is aware and
knowledgeable of the extent that the Accused OmniVision Products are
incorporated into end user products that are distributed in the United States.
54. The extent and nature of OmniVision’s customer support for its
customers and end customers is uniquely within Defendant OmniVision’s
knowledge. Defendant OmniVision has been compelled in prior cases to produce
discovery of its customers, end customers and customer support for companies
incorporating the Accused OmniVision Products sold and/or offered for sale in the
United States. (Godo Kaisha IP Bridge 1 v.. Omnivision Technologies, Inc., Civil
Action No. 16-290 (D. Del.)(Dkt. 160-1 at 18:25-19:3; 25:23-26:7.)
COUNT I: INFRINGEMENT OF U.S. PATENT NO. 6,211,509
28 Case 2:19-cv-10439-DPH-DRG ECF No. 25 filed 04/29/19 PageID.623 Page 29 of 59
55. Plaintiff incorporates by reference the allegations set forth in the
preceding paragraphs.
56. Defendant OmniVision has directly infringed and is infringing
literally and/or under the doctrine of equivalents, in violation of the §271(a) at least
claims 1, 2, 3, 17, 18, 21 and 22 of the ‘509 Patent at least during the period prior
to the expiration of the patent by making, using, importing, offering for sale and/or
selling CMOS imaging sensor products including but not limited to device model
numbers listed in Ex. H (“Accused OmniVision Products”), in this judicial district
and elsewhere throughout the United States.
57. As discussed in more detail in the General Allegations Section,
Defendant OmniVision has and continues to intentionally induce others, including
the Direct Infringers, to directly infringe the ‘509 patent in violation of 35 U.S.C.
§271(b), and those actions are undertaken with the specific intent that they will, in
fact, induce direct infringement and with full knowledge that Defendant
OmniVision’s products infringe one or more claims of each of the Patents-in-Suit
both literally and/or under the doctrine of equivalents.
58. Defendant Texas Instruments has directly infringed and is infringing
literally and/or under the doctrine of equivalents, in violation of the §271(a) at least
claims 1, 2, 3, 17, 18, 21, and 22 of the ‘509 Patent at least during the period prior
to the expiration of the patent by making, using, importing, offering for sale and/or
29 Case 2:19-cv-10439-DPH-DRG ECF No. 25 filed 04/29/19 PageID.624 Page 30 of 59
selling products incorporating one or more of the Accused OmniVision Products,
such as, inter alia, Automotive ADAS system-on-chip (SoC) processors TDA2x,
TDA2Eco and TDA3x, which incorporates OmniVision’s 10635 image sensor, in
this judicial district and elsewhere throughout the United States.
59. Defendant Smart Eye has directly infringed and is infringing literally
and/or under the doctrine of equivalents, in violation of the §271(a) at least claims
1, 2, 3, 17, 18, 21, and 22 of the ‘509 Patent at least during the period prior to the
expiration of the patent by making, using, importing, offering for sale and/or
selling products incorporating one or more of the Accused OmniVision Products,
such as, inter alia, Smart Eye’s 2-megapixel imaging solution which incorporates
OmniVision’s CMOS imaging sensor product numbers OV2311, in this judicial
district and elsewhere throughout the United States.
60. Defendant SMK has directly infringed and is infringing literally
and/or under the doctrine of equivalents, in violation of the §271(a) at least claims
1, 2, 3, 17, 18, 21, and 22 of the ‘509 Patent at least during the period prior to the
expiration of the patent by making, using, importing, offering for sale and/or
selling products incorporating one or more of the Accused OmniVision Products,
such as, inter alia, the Tesla Backup Camera, which incorporates OmniVision’s
CMOS imaging sensor product numbers OV10635, in this judicial district and
elsewhere throughout the United States.
30 Case 2:19-cv-10439-DPH-DRG ECF No. 25 filed 04/29/19 PageID.625 Page 31 of 59
61. As a non-limiting example of each Defendant’s infringement of the
‘509 Patent, set forth in Ex. I, is a preliminary claim chart showing infringement of
exemplary claims 1, 2, 3, 17, 18, 21 and 22 of the ‘509 Patent by Defendant
OmniVision’s OV8850 and OV13850 CMOS image sensor products.
62. Upon information and belief, each Defendant’s infringement of the
‘509 Patent by the OV8850 and OV1350 products is representative of and proof of
each Defendant infringement of the ‘509 Patent by all of the Accused OmniVision
Products as well as products incorporating the Accused OmniVision Products. The
Accused OmniVision Products comprise the same, or substantially similar,
structural features pertinent to infringement of the ‘509 Patent.
63. Defendant OmniVision has been on notice of the ‘509 Patent and
Defendant OmniVision’s infringement of the ‘509 Patent since at least 2015
pursuant to correspondence between Toshiba and OmniVision, and at least, March
3, 2016 pursuant to a letter to Shaw Hong, Chief Executive Officer and Chairman
of the Board for OmniVision, and Y. Vicky Chou, Senior Vice President of Global
Management and General Counsel for OmniVision, identifying the ‘509 patent.
64. Defendants Texas Instruments, Smart Eye and SMK have each been
on notice of the ‘509 Patent and each defendant’s respective infringement of the
‘509 Patent, since, at least, the date of this Complaint.
31 Case 2:19-cv-10439-DPH-DRG ECF No. 25 filed 04/29/19 PageID.626 Page 32 of 59
65. Upon information and belief, Defendant OmniVision’s continued
infringement of the ‘509 Patent has been and continues to be willful since at least
2015, and warrants the enhancement of damages awarded as a result of its
infringement. In particular, despite Defendant Omnivision’s prior knowledge of its
infringement, Defendant OmniVision has failed to stop infringing the ‘509 Patent.
66. Defendants are not licensed or otherwise authorized to make, use,
import, sell or offer to sell any devices encompassed by the claims in the ‘509
Patent, and Defendants’ conduct is, in every instance, without Plaintiff’s consent.
67. Upon information and belief, Defendants Texas Instruments’, Smart
Eye’s and SMK’s respective infringement of the ‘509 Patent is willful. Each
Defendants willful infringement of the ‘509 Patent renders this an exceptional case
within the meaning of 35 U.S.C. §285, justifying an award to Plaintiff of its
reasonable attorney fees and costs incurred in connection with this litigation.
68. By reason of Defendants’ infringing activities, Plaintiff has suffered,
and will continue to suffer, substantial damages in an amount to be proven at trial.
COUNT II: INFRINGEMENT OF U.S. PATENT NO. 6,150,676
69. Plaintiff incorporates by reference the allegations set forth in the
preceding paragraphs.
70. Defendant OmniVision has directly infringed and is infringing
literally and/or under the doctrine of equivalents, in violation of the §271(a) at least
32 Case 2:19-cv-10439-DPH-DRG ECF No. 25 filed 04/29/19 PageID.627 Page 33 of 59
claims 17, 19 and 20 of the ‘676 Patent at least during the period prior to the
expiration of the patent by making, using, importing, offering for sale and/or
selling CMOS imaging sensor products including but not limited to device model
numbers listed in Ex. H (“Accused OmniVision Products”), in this judicial district
and elsewhere throughout the United States.
71. As discussed in more detail in the General Allegations Section,
Defendant OmniVision has and continues to intentionally induce others, including
the Direct Infringers, to directly infringe the ‘676 patent in violation of 35 U.S.C.
§271(b), and those actions are undertaken with the specific intent that they will, in
fact, induce direct infringement and with full knowledge that Defendant
OmniVision’s products infringe one or more claims of each of the Patents-in-Suit
both literally and/or under the doctrine of equivalents.
72. Defendant Texas Instruments has directly infringed and is infringing
literally and/or under the doctrine of equivalents, in violation of the §271(a) at least
claims 17, 19 and 20 of the ‘676 Patent at least during the period prior to the
expiration of the patent by making, using, importing, offering for sale and/or
selling products incorporating one or more of the Accused OmniVision Products,
such as, inter alia, Automotive ADAS system-on-chip (SoC) processors TDA2x,
TDA2Eco and TDA3x, which incorporates OmniVision’s 10635 image sensor, in
this judicial district and elsewhere throughout the United States.
33 Case 2:19-cv-10439-DPH-DRG ECF No. 25 filed 04/29/19 PageID.628 Page 34 of 59
73. Defendant Smart Eye has directly infringed and is infringing literally
and/or under the doctrine of equivalents, in violation of the §271(a) at least claims
17, 19 and 20 of the ‘676 Patent at least during the period prior to the expiration of
the patent by making, using, importing, offering for sale and/or selling products
incorporating one or more of the Accused OmniVision Products, such as, inter
alia, Smart Eye’s 2-megapixel imaging solution which incorporates OmniVision’s
CMOS imaging sensor product numbers OV2311, in this judicial district and
elsewhere throughout the United States.
74. Defendant SMK has directly infringed and is infringing literally
and/or under the doctrine of equivalents, in violation of the §271(a) at least claims
17, 19 and 20 of the ‘676 Patent at least during the period prior to the expiration of
the patent by making, using, importing, offering for sale and/or selling products
incorporating one or more of the Accused OmniVision Products, such as, inter
alia, the Tesla Backup Camera, which incorporates OmniVision’s CMOS imaging
sensor product numbers OV10635, in this judicial district and elsewhere
throughout the United States.
75. As a non-limiting example of each Defendant’s infringement of the
‘676 Patent, set forth in Ex. J, is a preliminary claim chart showing infringement of
exemplary claims 17, 19 and 20 of the ‘676 Patent by Defendant OmniVision’s
OV8805 and OV13850 CMOS image sensor products.
34 Case 2:19-cv-10439-DPH-DRG ECF No. 25 filed 04/29/19 PageID.629 Page 35 of 59
76. Upon information and belief, each Defendant’s infringement of the
‘676 Patent by the OV8805 and OV1350 products is representative of and proof of
each Defendant’s infringement of the ‘676 Patent by all of the Accused
OmniVision Products as well as products incorporating the Accused OmniVision
Products. The Accused OmniVision Products comprise the same, or substantially
similar, structural features pertinent to infringement of the ‘676 Patent.
77. Defendant OmniVision has been on notice of the ‘676 Patent and
Defendant OmniVision’s infringement of the ‘676 Patent since at least 2015
pursuant to correspondence between Toshiba and OmniVision, and at least, March
3, 2016 pursuant to a letter to Shaw Hong, Chief Executive Officer and Chairman
of the Board for OmniVision, and Y. Vicky Chou, Senior Vice President of Global
Management and General Counsel for OmniVision, identifying the ‘676 patent,
and due to citation to the ‘676 patent by OmniVision’s U.S. Patent No. 6,486,521.
78. Defendants Texas Instruments, Smart Eye and SMK have each been
on notice of the ‘676 Patent and each defendant’s respective infringement of the
‘676 Patent, since, at least, the date of this Complaint.
79. Upon information and belief, Defendant OmniVision’s continued
infringement of the ‘676 Patent has been and continues to be willful since at least
2015, and warrants the enhancement of damages awarded as a result of its
35 Case 2:19-cv-10439-DPH-DRG ECF No. 25 filed 04/29/19 PageID.630 Page 36 of 59
infringement. In particular, despite Defendant OmniVision’s prior knowledge of its
infringement, Defendant OmniVision has failed to stop infringing the ‘676 Patent.
80. Defendants are not licensed or otherwise authorized to make, use,
import, sell or offer to sell any devices encompassed by the claims in the ‘676
Patent, and Defendants’ conduct is, in every instance, without Plaintiff’s consent.
81. Upon information and belief, Defendants Texas Instruments’, Smart
Eye’s and SMK’s respective infringement of the ‘676 Patent is willful. Each
Defendants willful infringement of the ‘676 Patent renders this an exceptional case
within the meaning of 35 U.S.C. §285, justifying an award to Plaintiff of its
reasonable attorney fees and costs incurred in connection with this litigation.
82. By reason of Defendants’ infringing activities, Plaintiff has suffered,
and will continue to suffer, substantial damages in an amount to be proven at trial.
COUNT III: INFRINGEMENT OF U.S. PATENT NO. 6,521,926
83. Plaintiff incorporates by reference the allegations set forth in the
preceding paragraphs.
84. Defendant OmniVision has directly infringed and is infringing
literally and/or under the doctrine of equivalents, in violation of the §271(a) at least
claims 8 and 14 of the ‘926 Patent at least during the period prior to the expiration
of the patent by making, using, importing, offering for sale and/or selling CMOS
imaging sensor products including but not limited to device model numbers listed
36 Case 2:19-cv-10439-DPH-DRG ECF No. 25 filed 04/29/19 PageID.631 Page 37 of 59
in Ex. H (“Accused OmniVision Products”), in this judicial district and elsewhere
throughout the United States.
85. As discussed in more detail in the General Allegations Section,
Defendant OmniVision has and continues to intentionally induce others, including
the Direct Infringers, to directly infringe the ‘926 patent in violation of 35 U.S.C.
§271(b), and those actions are undertaken with the specific intent that they will, in
fact, induce direct infringement and with full knowledge that Defendant
OmniVision’s products infringe one or more claims of each of the Patents-in-Suit
both literally and/or under the doctrine of equivalents.
86. Defendant Texas Instruments has directly infringed and is infringing
literally and/or under the doctrine of equivalents, in violation of the §271(a) at least
claims 8 and 14 of the ‘926 Patent at least during the period prior to the expiration
of the patent by making, using, importing, offering for sale and/or selling products
incorporating one or more of the Accused OmniVision Products, such as, inter
alia, Automotive ADAS system-on-chip (SoC) processors TDA2x, TDA2Eco and
TDA3x, which incorporates OmniVision’s 10635 image sensor, in this judicial
district and elsewhere throughout the United States.
87. Defendant Smart Eye has directly infringed and is infringing literally
and/or under the doctrine of equivalents, in violation of the §271(a) at least claims
8 and 14 of the ‘926 Patent at least during the period prior to the expiration of the
37 Case 2:19-cv-10439-DPH-DRG ECF No. 25 filed 04/29/19 PageID.632 Page 38 of 59
patent by making, using, importing, offering for sale and/or selling products
incorporating one or more of the Accused OmniVision Products, such as, inter
alia, Smart Eye’s 2-megapixel imaging solution which incorporates OmniVision’s
CMOS imaging sensor product numbers OV2311, in this judicial district and
elsewhere throughout the United States.
88. Defendant SMK has directly infringed and is infringing literally
and/or under the doctrine of equivalents, in violation of the §271(a) at least claims
8 and 14 of the ‘926 Patent at least during the period prior to the expiration of the
patent by making, using, importing, offering for sale and/or selling products
incorporating one or more of the Accused OmniVision Products, such as, inter
alia, the Tesla Backup Camera, which incorporates OmniVision’s CMOS imaging
sensor product numbers OV10635, in this judicial district and elsewhere
throughout the United States.
89. As a non-limiting example of each Defendant’s infringement of the
‘926 Patent, set forth in Ex. K, is a preliminary claim chart showing infringement
of exemplary claims 8 and 14 of the ‘926 Patent by Defendant OmniVision’s
OV13850 CMOS image sensor product.
90. Upon information and belief, each Defendant’s infringement of the
‘926 Patent by the OV1350 product is representative of and proof of each
Defendant’s infringement of the ‘926 Patent by all of the Accused OmniVision
38 Case 2:19-cv-10439-DPH-DRG ECF No. 25 filed 04/29/19 PageID.633 Page 39 of 59
Products as well as products incorporating the Accused OmniVision Products. The
Accused OmniVision Products comprise the same, or substantially similar,
structural features pertinent to infringement of the ‘926 Patent.
91. Defendant OmniVision has been on notice of the ‘926 Patent and
Defendant OmniVision’s infringement of the ‘926 Patent since at least 2015
pursuant to correspondence between Toshiba and OmniVision, and at least, March
3, 2016 pursuant to a letter to Shaw Hong, Chief Executive Officer and Chairman
of the Board for OmniVision, and Y. Vicky Chou, Senior Vice President of Global
Management and General Counsel for OmniVision, identifying the ‘926 patent.
92. Defendants Texas Instruments, Smart Eye and SMK have each been
on notice of the ‘926 Patent and each defendant’s respective infringement of the
‘926 Patent, since, at least, the date of this Complaint.
93. Upon information and belief, Defendant OmniVision’s continued
infringement of the ‘926 Patent has been and continues to be willful since at least
2015, and warrants the enhancement of damages awarded as a result of its
infringement. In particular, despite Defendant OmniVision’s prior knowledge of its
infringement, Defendant OmniVision has failed to stop infringing the ‘926 Patent.
94. Defendants are not licensed or otherwise authorized to make, use,
import, sell or offer to sell any semiconductor devices encompassed by the claims
39 Case 2:19-cv-10439-DPH-DRG ECF No. 25 filed 04/29/19 PageID.634 Page 40 of 59
in the ‘926 Patent, and Defendants’ conduct is, in every instance, without
Plaintiff’s consent.
95. Upon information and belief, Defendants Texas Instruments’, Smart
Eye’s and SMK’s respective infringement of the ‘926 Patent is willful. Each
Defendants willful infringement of the ‘926 Patent renders this an exceptional case
within the meaning of 35 U.S.C. §285, justifying an award to Plaintiff of its
reasonable attorney fees and costs incurred in connection with this litigation.
96. By reason of Defendants’ infringing activities, Plaintiff has suffered,
and will continue to suffer, substantial damages in an amount to be proven at trial.
COUNT IV: INFRINGEMENT OF U.S. PATENT NO. 7,928,483
97. Plaintiff incorporates by reference the allegations set forth in the
preceding paragraphs.
98. Defendant OmniVision has directly infringed and is infringing
literally and/or under the doctrine of equivalents, in violation of the §271(a) at least
claims 1 and 2 of the ‘483 Patent at least during the period prior to the expiration
of the patent by making, using, importing, offering for sale and/or selling CMOS
imaging sensor products including but not limited to device model numbers listed
in Ex. H (“Accused OmniVision Products”), in this judicial district and elsewhere
throughout the United States.
40 Case 2:19-cv-10439-DPH-DRG ECF No. 25 filed 04/29/19 PageID.635 Page 41 of 59
99. As discussed in more detail in the General Allegations Section,
Defendant OmniVision has and continues to intentionally induce others, including
the Direct Infringers, to directly infringe the ‘483 patent in violation of 35 U.S.C.
§271(b), and those actions are undertaken with the specific intent that they will, in
fact, induce direct infringement and with full knowledge that Defendant
OmniVision’s products infringe one or more claims of each of the Patents-in-Suit
both literally and/or under the doctrine of equivalents.
100. Defendant Texas Instruments has directly infringed and is infringing
literally and/or under the doctrine of equivalents, in violation of the §271(a) at least
claims 1 and 2 of the ‘483 Patent at least during the period prior to the expiration
of the patent by making, using, importing, offering for sale and/or selling products
incorporating one or more of the Accused OmniVision Products, such as, inter
alia, Automotive ADAS system-on-chip (SoC) processors TDA2x, TDA2Eco and
TDA3x, which incorporates OmniVision’s 10635 image sensor, in this judicial
district and elsewhere throughout the United States.
101. Defendant Smart Eye has directly infringed and is infringing literally
and/or under the doctrine of equivalents, in violation of the §271(a) at least claims
1 and 2 of the ‘483 Patent at least during the period prior to the expiration of the
patent by making, using, importing, offering for sale and/or selling products
incorporating one or more of the Accused OmniVision Products, such as, inter
41 Case 2:19-cv-10439-DPH-DRG ECF No. 25 filed 04/29/19 PageID.636 Page 42 of 59
alia, Smart Eye’s 2-megapixel imaging solution which incorporates OmniVision’s
CMOS imaging sensor product numbers OV2311, in this judicial district and
elsewhere throughout the United States.
102. Defendant SMK has directly infringed and is infringing literally
and/or under the doctrine of equivalents, in violation of the §271(a) at least claims
1 and 2 of the ‘483 Patent at least during the period prior to the expiration of the
patent by making, using, importing, offering for sale and/or selling products
incorporating one or more of the Accused OmniVision Products, such as, inter
alia, the Tesla Backup Camera, which incorporates OmniVision’s CMOS imaging
sensor product numbers OV10635, in this judicial district and elsewhere
throughout the United States.
103. As a non-limiting example of each Defendant’s infringement of the
‘483 Patent, set forth in Ex. L, is a preliminary claim chart showing infringement
of exemplary claims 1 and 2 of the ‘483 Patent by Defendant OmniVision’s -
OV8850 and OV13850 CMOS image sensor products.
104. Upon information and belief, each Defendant’s infringement of the
‘483 Patent by the OV8850 and OV1350 products is representative of and proof of
each Defendant’s infringement of the ‘483 Patent by all of the Accused
OmniVision Products as well as products incorporating the Accused OmniVision
42 Case 2:19-cv-10439-DPH-DRG ECF No. 25 filed 04/29/19 PageID.637 Page 43 of 59
Products. The Accused OmniVision Products comprise the same, or substantially
similar, structural features pertinent to infringement of the ‘483 Patent.
105. Defendant OmniVision has been on notice of the ‘483 Patent and
Defendant’s infringement of the ‘483 Patent since at least 2015 pursuant to
correspondence between Toshiba and OmniVision, and at least, March 3, 2016
pursuant to a letter to Shaw Hong, Chief Executive Officer and Chairman of the
Board for OmniVision, and Y. Vicky Chou, Senior Vice President of Global
Management and General Counsel for OmniVision, identifying the ‘483 patent.
106. Defendants Texas Instruments, Smart Eye and SMK have each been
on notice of the ‘483 Patent and each defendant’s respective infringement of the
‘483 Patent, since, at least, the date of this Complaint.
107. Upon information and belief, Defendant OmniVision’s continued
infringement of the ‘483 Patent has been and continues to be willful since at least
2015, and warrants the enhancement of damages awarded as a result of its
infringement. In particular, despite Defendant OmniVision’s prior knowledge of its
infringement, Defendant OmniVision has failed to stop infringing the ‘483 Patent.
108. Defendants are not licensed or otherwise authorized to make, use,
import, sell or offer to sell any semiconductor devices encompassed by the claims
in the ‘483 Patent, and Defendants’ conduct is, in every instance, without
Plaintiff’s consent.
43 Case 2:19-cv-10439-DPH-DRG ECF No. 25 filed 04/29/19 PageID.638 Page 44 of 59
109. Upon information and belief, Defendants Texas Instruments’, Smart
Eye’s and SMK’s respective infringement of the ‘483 Patent is willful. Each
Defendants willful infringement of the ‘483 Patent renders this an exceptional case
within the meaning of 35 U.S.C. §285, justifying an award to Plaintiff of its
reasonable attorney fees and costs incurred in connection with this litigation.
110. By reason of Defendants’ infringing activities, Plaintiff has suffered,
and will continue to suffer, substantial damages in an amount to be proven at trial.
COUNT V: INFRINGEMENT OF U.S. PATENT NO. 8,854,521
111. Plaintiff incorporates by reference the allegations set forth in the
preceding paragraphs.
112. Defendant OmniVision has directly infringed and is infringing
literally and/or under the doctrine of equivalents, in violation of the §271(a) at least
claim 1 of the ‘521 Patent at least during the period prior to the expiration of the
patent by making, using, importing, offering for sale and/or selling CMOS imaging
sensor products including but not limited to device model numbers listed in Ex. H
(“Accused OmniVision Products”), in this judicial district and elsewhere
throughout the United States.
113. As discussed in more detail in the General Allegations Section,
Defendant OmniVision has and continues to intentionally induce others, including
the Direct Infringers, to directly infringe the ‘521 patent in violation of 35 U.S.C.
44 Case 2:19-cv-10439-DPH-DRG ECF No. 25 filed 04/29/19 PageID.639 Page 45 of 59
§271(b), and those actions are undertaken with the specific intent that they will, in
fact, induce direct infringement and with full knowledge that Defendant
OmniVision’s products infringe one or more claims of each of the Patents-in-Suit
both literally and/or under the doctrine of equivalents.
114. Defendant Texas Instruments has directly infringed and is infringing
literally and/or under the doctrine of equivalents, in violation of the §271(a) at least
claim 1 of the ‘521 Patent at least during the period prior to the expiration of the
patent by making, using, importing, offering for sale and/or selling products
incorporating one or more of the Accused OmniVision Products, such as, inter
alia, Automotive ADAS system-on-chip (SoC) processors TDA2x, TDA2Eco and
TDA3x, which incorporates OmniVision’s 10635 image sensor, in this judicial
district and elsewhere throughout the United States.
115. Defendant Smart Eye has directly infringed and is infringing literally
and/or under the doctrine of equivalents, in violation of the §271(a) at least claim 1
of the ‘521 Patent at least during the period prior to the expiration of the patent by
making, using, importing, offering for sale and/or selling products incorporating
one or more of the Accused OmniVision Products, such as, inter alia, Smart Eye’s
2-megapixel imaging solution which incorporates OmniVision’s CMOS imaging
sensor product numbers OV2311, in this judicial district and elsewhere throughout
the United States.
45 Case 2:19-cv-10439-DPH-DRG ECF No. 25 filed 04/29/19 PageID.640 Page 46 of 59
116. Defendant SMK has directly infringed and is infringing literally
and/or under the doctrine of equivalents, in violation of the §271(a) at least claim 1
of the ‘521 Patent at least during the period prior to the expiration of the patent by
making, using, importing, offering for sale and/or selling products incorporating
one or more of the Accused OmniVision Products, such as, inter alia, the Tesla
Backup Camera, which incorporates OmniVision’s CMOS imaging sensor product
numbers OV10635, in this judicial district and elsewhere throughout the United
States.
117. As a non-limiting example of each Defendant’s infringement of the
‘521 Patent, set forth in Ex. M, is a preliminary claim chart showing infringement
of exemplary claim 1 of the ‘521 Patent by Defendant OmniVision’s OV8850
CMOS image sensor product.
118. Upon information and belief, each Defendant’s infringement of the
‘521 Patent by the OV8850 product is representative of and proof of each
Defendant’s infringement of the ‘521 Patent by all of the Accused OmniVision
Products as well as products incorporating the Accused OmniVision Products.. The
Accused ‘521 Devices comprise the same, or substantially similar, structural
features pertinent to infringement of the ‘521 Patent.
119. Defendant OmniVision has been on notice of the ‘521 Patent and
Defendant OmniVision’s infringement of the ‘521 Patent since at least 2015
46 Case 2:19-cv-10439-DPH-DRG ECF No. 25 filed 04/29/19 PageID.641 Page 47 of 59
pursuant to correspondence between Toshiba and OmniVision, and at least, March
3, 2016 pursuant to a letter to Shaw Hong, Chief Executive Officer and Chairman
of the Board for OmniVision, and Y. Vicky Chou, Senior Vice President of Global
Management and General Counsel for OmniVision, identifying the Toshiba’s
patents related to CMOS image sensor technology.
120. Defendants Texas Instruments, Smart Eye and SMK have each been
on notice of the ‘521 Patent and each defendant’s respective infringement of the
‘521 Patent, since, at least, the date of this Complaint.
121. Upon information and belief, Defendant OmniVision’s continued
infringement of the ‘521 Patent has been and continues to be willful since at least
2015,and warrants the enhancement of damages awarded as a result of its
infringement. In particular, despite Defendant OmniVision’s prior knowledge of its
infringement, Defendant OmniVision has failed to stop infringing the ‘521 Patent.
122. Defendants are not licensed or otherwise authorized to make, use,
import, sell or offer to sell any semiconductor devices encompassed by the claims
in the ‘521 Patent, and Defendants’ conduct is, in every instance, without
Plaintiff’s consent.
123. Upon information and belief, Defendants Texas Instruments’, Smart
Eye’s and SMK’s respective infringement of the ‘521 Patent is willful. Each
Defendants willful infringement of the ‘521 Patent renders this an exceptional case
47 Case 2:19-cv-10439-DPH-DRG ECF No. 25 filed 04/29/19 PageID.642 Page 48 of 59
within the meaning of 35 U.S.C. §285, justifying an award to Plaintiff of its
reasonable attorney fees and costs incurred in connection with this litigation.
124. By reason of Defendants’ infringing activities, Plaintiff has suffered,
and will continue to suffer, substantial damages in an amount to be proven at trial.
COUNT VI: INFRINGEMENT OF U.S. PATENT NO. RE46123
125. Plaintiff incorporates by reference the allegations set forth in the
preceding paragraphs.
126. Defendant OmniVision has directly infringed and is infringing
literally and/or under the doctrine of equivalents, in violation of the §271(a) at least
claims 1-4, 6-8 of the ‘123 Patent at least during the period prior to the expiration
of the patent by making, using, importing, offering for sale and/or selling CMOS
imaging sensor products including but not limited to device model numbers listed
in Ex. H (“Accused OmniVision Products”), in this judicial district and elsewhere
throughout the United States.
127. As discussed in more detail in the General Allegations Section,
Defendant OmniVision has and continues to intentionally induce others, including
the Direct Infringers, to directly infringe the ‘123 patent in violation of 35 U.S.C.
§271(b), and those actions are undertaken with the specific intent that they will, in
fact, induce direct infringement and with full knowledge that Defendant
48 Case 2:19-cv-10439-DPH-DRG ECF No. 25 filed 04/29/19 PageID.643 Page 49 of 59
OmniVision’s products infringe one or more claims of each of the Patents-in-Suit
both literally and/or under the doctrine of equivalents.
128. Defendant Texas Instruments has directly infringed and is infringing
literally and/or under the doctrine of equivalents, in violation of the §271(a) at least
claims 11-4, 6-8 of the ‘123 Patent at least during the period prior to the expiration
of the patent by making, using, importing, offering for sale and/or selling products
incorporating one or more of the Accused OmniVision Products, such as, inter
alia, Automotive ADAS system-on-chip (SoC) processors TDA2x, TDA2Eco and
TDA3x, which incorporates OmniVision’s 10635 image sensor, in this judicial
district and elsewhere throughout the United States.
129. Defendant Smart Eye has directly infringed and is infringing literally
and/or under the doctrine of equivalents, in violation of the §271(a) at least claims
1-4, 6-8 of the ‘123 Patent at least during the period prior to the expiration of the
patent by making, using, importing, offering for sale and/or selling products
incorporating one or more of the Accused OmniVision Products, such as, inter
alia, Smart Eye’s 2-megapixel imaging solution which incorporates OmniVision’s
CMOS imaging sensor product numbers OV2311, in this judicial district and
elsewhere throughout the United States.
130. Defendant SMK has directly infringed and is infringing literally
and/or under the doctrine of equivalents, in violation of the §271(a) at least claims
49 Case 2:19-cv-10439-DPH-DRG ECF No. 25 filed 04/29/19 PageID.644 Page 50 of 59
1-4, 6-8 of the ‘123 Patent at least during the period prior to the expiration of the
patent by making, using, importing, offering for sale and/or selling products
incorporating one or more of the Accused OmniVision Products, such as, inter
alia, the Tesla Backup Camera, which incorporates OmniVision’s CMOS imaging
sensor product numbers OV10635, in this judicial district and elsewhere
throughout the United States.
131. As a non-limiting example of each Defendant’s infringement of the
‘123 Patent, set forth in Ex. N, is a preliminary claim chart showing infringement
of exemplary claims 1-4, 6-8 of the ‘123 Patent by Defendant OmniVision’s
OV8850 and OV13850 CMOS image sensor products.
132. Upon information and belief, each Defendant’s infringement of the
‘123 Patent by the OV8850 product is representative of and proof of each
Defendant’s infringement of the ‘123 Patent by all of the Accused OmniVision
Products as well as products incorporating the Accused OmniVision Products. The
Accused OmniVision Products comprise the same, or substantially similar,
structural features pertinent to infringement of the ‘123 Patent.
133. Defendant OmniVision has been on notice of the ‘123 Patent and
Defendant’s infringement of the ‘123 Patent since at least 2015 pursuant to
correspondence between Toshiba and OmniVision, and at least, March 3, 2016
pursuant to a letter to Shaw Hong, Chief Executive Officer and Chairman of the
50 Case 2:19-cv-10439-DPH-DRG ECF No. 25 filed 04/29/19 PageID.645 Page 51 of 59
Board for OmniVision, and Y. Vicky Chou, Senior Vice President of Global
Management and General Counsel for OmniVision, identifying the ‘123 patent.
134. Defendants Texas Instruments, Smart Eye and SMK have each been
on notice of the ‘123 Patent and each defendant’s respective infringement of the
‘123 Patent, since, at least, the date of this Complaint.
135. Upon information and belief, Defendant OmniVision’s continued
infringement of the ‘123 Patent has been and continues to be willful since at least
2015, and warrants the enhancement of damages awarded as a result of its
infringement. In particular, despite Defendant OmniVision’s knowledge of its
infringement, Defendant has failed to stop infringing the ‘123 Patent.
136. Defendants are not licensed or otherwise authorized to make, use,
import, sell or offer to sell any semiconductor devices encompassed by the claims
in the ‘123 Patent, and Defendants’ conduct is, in every instance, without
Plaintiff’s consent.
137. Upon information and belief, Defendants Texas Instruments’, Smart
Eye’s and SMK’s respective infringement of the ‘123 Patent is willful. Each
Defendants willful infringement of the ‘123 Patent renders this an exceptional case
within the meaning of 35 U.S.C. §285, justifying an award to Plaintiff of its
reasonable attorney fees and costs incurred in connection with this litigation.
51 Case 2:19-cv-10439-DPH-DRG ECF No. 25 filed 04/29/19 PageID.646 Page 52 of 59
138. By reason of Defendants’ infringing activities, Plaintiff has suffered,
and will continue to suffer, substantial damages in an amount to be proven at trial.
COUNT VI: INFRINGEMENT OF U.S. PATENT NO. 8,178,913
139. Plaintiff incorporates by reference the allegations set forth in the
preceding paragraphs.
140. Defendant OmniVision has directly infringed and is infringing
literally and/or under the doctrine of equivalents, in violation of the §271(a) at least
claim 1 of the ‘913 Patent at least during the period prior to the expiration of the
patent by making, using, importing, offering for sale and/or selling CMOS imaging
sensor products including but not limited to device model numbers listed in Ex. H
(“Accused OmniVision Products”), in this judicial district and elsewhere
throughout the United States.
141. As discussed in more detail in the General Allegations Section,
Defendant OmniVision has and continues to intentionally induce others, including
the Direct Infringers, to directly infringe the ‘913 patent in violation of 35 U.S.C.
§271(b), and those actions are undertaken with the specific intent that they will, in
fact, induce direct infringement and with full knowledge that Defendant
OmniVision’s products infringe one or more claims of each of the Patents-in-Suit
both literally and/or under the doctrine of equivalents.
52 Case 2:19-cv-10439-DPH-DRG ECF No. 25 filed 04/29/19 PageID.647 Page 53 of 59
142. Defendant Texas Instruments has directly infringed and is infringing
literally and/or under the doctrine of equivalents, in violation of the §271(a) at least
claim 1 of the ‘913 Patent at least during the period prior to the expiration of the
patent by making, using, importing, offering for sale and/or selling products
incorporating one or more of the Accused OmniVision Products, such as, inter
alia, Automotive ADAS system-on-chip (SoC) processors TDA2x, TDA2Eco and
TDA3x, which incorporates OmniVision’s 10635 image sensor, in this judicial
district and elsewhere throughout the United States.
143. Defendant Smart Eye has directly infringed and is infringing literally
and/or under the doctrine of equivalents, in violation of the §271(a) at least claim 1
of the ‘913 Patent at least during the period prior to the expiration of the patent by
making, using, importing, offering for sale and/or selling products incorporating
one or more of the Accused OmniVision Products, such as, inter alia, Smart Eye’s
2-megapixel imaging solution which incorporates OmniVision’s CMOS imaging
sensor product numbers OV2311, in this judicial district and elsewhere throughout
the United States.
144. Defendant SMK has directly infringed and is infringing literally
and/or under the doctrine of equivalents, in violation of the §271(a) at least claim 1
of the ‘913 Patent at least during the period prior to the expiration of the patent by
making, using, importing, offering for sale and/or selling products incorporating
53 Case 2:19-cv-10439-DPH-DRG ECF No. 25 filed 04/29/19 PageID.648 Page 54 of 59
one or more of the Accused OmniVision Products, such as, inter alia, the Tesla
Backup Camera, which incorporates OmniVision’s CMOS imaging sensor product
numbers OV10635, in this judicial district and elsewhere throughout the United
States.
145. As a non-limiting example of each Defendant’s infringement of the
‘913 Patent, set forth in Ex. O, is a preliminary claim chart showing infringement
of exemplary claim 1 of the ‘913 Patent by Defendant OmniVision’s OV8850 and
OV13850 CMOS image sensor products.
146. Upon information and belief, each Defendant’s infringement of the
‘913 Patent by the OV8850 product is representative of and proof of each
Defendant’s infringement of the ‘913 Patent by all of the Accused OmniVision
Products as well as products incorporating the Accused OmniVision Products. The
Accused OmniVision Products comprise the same, or substantially similar,
structural features pertinent to infringement of the ‘913 Patent.
147. Defendant OmniVision has been on notice of the ‘913 Patent and
Defendant OmniVision’s infringement of the ‘913 Patent since at least 2015
pursuant to correspondence between Toshiba and OmniVision, and at least, March
3, 2016 pursuant to a letter to Shaw Hong, Chief Executive Officer and Chairman
of the Board for OmniVision, and Y. Vicky Chou, Senior Vice President of Global
Management and General Counsel for OmniVision, identifying Toshiba’s patents
54 Case 2:19-cv-10439-DPH-DRG ECF No. 25 filed 04/29/19 PageID.649 Page 55 of 59
related to CMOS image sensor technology, and a patent within the same family as
the ‘913 patent.
148. Defendants Texas Instruments, Smart Eye and SMK have each been
on notice of the ‘913 Patent and each defendant’s respective infringement of the
‘913 Patent, since, at least, the date of this Complaint.
149. Upon information and belief, Defendant OmniVision’s continued
infringement of the ‘913 Patent has been and continues to be willful since at least
2015, and warrants the enhancement of damages awarded as a result of its
infringement. In particular, despite Defendant OmniVision’s knowledge of its
infringement, Defendant OmniVision has failed to stop infringing the ‘913 Patent.
150. Defendants are not licensed or otherwise authorized to make, use,
import, sell or offer to sell any semiconductor devices encompassed by the claims
in the ‘913 Patent, and Defendants’ conduct is, in every instance, without
Plaintiff’s consent.
151. Upon information and belief, Defendants Texas Instruments’, Smart
Eye’s and SMK’s respective infringement of the ‘913 Patent is willful. Each
Defendants willful infringement of the ‘913 Patent renders this an exceptional case
within the meaning of 35 U.S.C. §285, justifying an award to Plaintiff of its
reasonable attorney fees and costs incurred in connection with this litigation.
55 Case 2:19-cv-10439-DPH-DRG ECF No. 25 filed 04/29/19 PageID.650 Page 56 of 59
152. By reason of Defendants’ infringing activities, Plaintiff has suffered,
and will continue to suffer, substantial damages in an amount to be proven at trial.
PRAYER FOR RELIEF
WHEREFORE, Plaintiff requests this Court enter judgment as follows:
A. That the ‘509, ‘676, ‘926, ‘483, ‘521, ‘123 and ‘913 patents are valid
and enforceable;
B. That Defendant OmniVision has directly and indirectly infringed the
‘509 Patent, the ‘676 Patent, the ‘926 Patent, the ‘483 Patent, the ‘521 Patent, the
‘123 Patent, and ‘913 Patent;
C. That Defendant Texas Instruments, Smart Eye and SMK have directly
infringed the ‘509 Patent, the ‘676 Patent, the ‘926 Patent, the ‘483 Patent, the
‘521 Patent, the ‘123 Patent, and ‘913 Patent;
D. That such infringement is willful;
E. That Defendants account for and pay to Plaintiff all damages pursuant
to 35 U.S.C. § 284 to adequately compensate Plaintiff for Defendants’
infringement of the Patents-in-Suit, but in no event less than a reasonable royalty
for the use made by Defendants of the invention set forth in the Patents-in-Suit;
F. That Plaintiff receives enhanced damages, in the form of treble
damages, pursuant to 35 U.S.C. § 284;
G. That this is an exceptional case under 35 U.S.C. § 285;
56 Case 2:19-cv-10439-DPH-DRG ECF No. 25 filed 04/29/19 PageID.651 Page 57 of 59
H. That Defendants pay Plaintiff all of Plaintiff’s reasonable attorneys’
fees and expenses pursuant to 35 U.S.C. § 285;
I. That Plaintiff be granted pre-judgment and post-judgment interest in
accordance with 35 U.S.C. § 284 on the damages caused to it by reason of
Defendants’ infringement of the Patents-in-Suit, including pre-judgment and
post-judgment interest on any enhanced damages or attorneys’ fees award;
J. That costs be awarded in accordance with 35 U.S.C. § 284 to Plaintiff;
and
K. That Plaintiff be granted such other and further relief as the Court may
deem just and proper under the circumstances.
DEMAND FOR JURY TRIAL
Plaintiff hereby demands a trial by jury on all issues so triable in this action.
57 Case 2:19-cv-10439-DPH-DRG ECF No. 25 filed 04/29/19 PageID.652 Page 58 of 59
Dated: April 29, 2019 Respectfully submitted,
By: /s/ Jaye Quadrozzi Jaye Quadrozzi Rodger D. Young YOUNG & ASSOCIATES Orchards Corporate Center 27725 Stansbury Boulevard, Suite 125 Farmington Hills, Michigan 48334 [email protected] +1 248 353 8620 (t) +1 248 479 7828 (f)
Zachary D. Silbersher Sergey Kolmykov KROUB, SILBERSHER & KOLMYKOV PLLC 305 Broadway, 7th Floor New York, NY 10007 (212) 323-7442 [email protected] [email protected]
Attorneys for Plaintiff
58 Case 2:19-cv-10439-DPH-DRG ECF No. 25 filed 04/29/19 PageID.653 Page 59 of 59
CERTIFICATE OF SERVICE
I hereby certify that on April 29, 2019, I, Zachary D. Silbersher,
electronically filed the foregoing paper with the Clerk of the Court using the ECF
system which will send notification of such filing to all counsel of record,
including counsel for defendant OmniVision Technologies, Inc.
By: /s/ Zachary D. Silbersher Zachary D. Silbersher KROUB, SILBERSHER & KOLMYKOV PLLC 305 Broadway, 7th Floor New York, NY 10007 (212) 323-7442 [email protected]
59